 | • レポートコード：MRC2401A097 • 出版社/出版日：Transparency Market Research / 2023年11月 • レポート形態：英文、PDF、160ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| デジタルPCR（dPCR）・定量PCR（qPCR）市場-レポート範囲 TMRの調査レポート「世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場の収益を提供しています。また、2023年から2031年までの世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場の複合年間成長率（CAGR %）も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、デジタルPCR（dPCR）・定量PCR（qPCR）市場を理解しました。 二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場の競争状況について掘り下げています。世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場で事業を展開する主要プレイヤーを特定し、各プレイヤーを様々な属性でプロファイルしています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場におけるプレイヤーの属性です。 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場レポートで回答された主な質問 - 予測期間中の全地域におけるデジタルPCR（dPCR）・定量PCR（qPCR）の売上高/収益は？ - 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場におけるビジネスチャンスは？ - 市場の主な促進要因、阻害要因、機会、脅威は？ - 予測期間中に最も速いCAGRで拡大する地域市場は？ - 2031年に世界で最も高い収益を上げると予測されるセグメントは？ - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？ - 世界市場で事業を展開する各企業の市場ポジションは？ 調査目的・調査アプローチ 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、主要セグメントの過去と予測期間末の市場シェアの比較も可能です。 本レポートでは、世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場を製品、エンドユーザー、地域の観点から分析。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界デジタルPCR（dPCR）・定量PCR（qPCR）市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。 |
1. 序論
2. 仮定・調査方法
3. エグゼクティブサマリー：世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場
4. 市場概要
5. 主要インサイト
6. 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測：製品種類別
7. 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測：用途別
8. 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測：エンドユーザー別
9. 世界のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測：地域別
10. 北米のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測
11. ヨーロッパのデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測
12. アジア太平洋のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測
13. 中南米のデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測
14. 中東・アフリカのデジタルPCR（dPCR）・定量PCR（qPCR）市場分析・予測
15. 競争状況
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Applications of real-time PCR in the continuum of care and patient management.
5.2. Strengths of dPCR and qPCR
5.3. Key product/brand Analysis
5.4. Technological Advancements
5.5. Top 3 players operating in the market space
5.6. COVID Impact Analysis
6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2023–2031
6.3.1. Quantitative PCR
6.3.1.1. Reagents & Consumables
6.3.1.2. Instruments
6.3.1.3. Software
6.3.2. Digital PCR
6.3.2.1. Reagents & Consumables
6.3.2.2. Instruments
6.3.2.3. Software
6.4. Market Attractiveness Analysis, by Product Type
7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2023–2031
7.3.1. Clinical Applications
7.3.2. Research Applications
7.3.3. Pathogen Testing
7.3.4. Oncology Testing
7.3.5. Blood Screening
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2023–2031
8.3.1. Hospitals & Diagnostic Centers
8.3.2. Research Laboratories & Academic Institutes
8.3.3. Pharmaceutical & Biotechnology Companies
8.3.4. Clinical Research Organizations
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2023–2031
10.2.1. Quantitative PCR
10.2.1.1. Reagents & Consumables
10.2.1.2. Instruments
10.2.1.3. Software
10.2.2. Digital PCR
10.2.2.1. Reagents & Consumables
10.2.2.2. Instruments
10.2.2.3. Software
10.3. Market Value Forecast, by Application, 2023–2031
10.3.1. Clinical Applications
10.3.2. Research Applications
10.3.3. Pathogen Testing
10.3.4. Oncology Testing
10.3.5. Blood Screening
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2023–2031
10.4.1. Hospitals & Diagnostic Centers
10.4.2. Research Laboratories & Academic Institutes
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Clinical Research Organizations
10.4.5. Others
10.5. Market Value Forecast, by Country, 2023–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2023–2031
11.2.1. Quantitative PCR
11.2.1.1. Reagents & Consumables
11.2.1.2. Instruments
11.2.1.3. Software
11.2.2. Digital PCR
11.2.2.1. Reagents & Consumables
11.2.2.2. Instruments
11.2.2.3. Software
11.3. Market Value Forecast, by Application, 2023–2031
11.3.1. Clinical Applications
11.3.2. Research Applications
11.3.3. Pathogen Testing
11.3.4. Oncology Testing
11.3.5. Blood Screening
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2023–2031
11.4.1. Hospitals & Diagnostic Centers
11.4.2. Research Laboratories & Academic Institutes
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Clinical Research Organizations
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2023–2031
12.2.1. Quantitative PCR
12.2.1.1. Reagents & Consumables
12.2.1.2. Instruments
12.2.1.3. Software
12.2.2. Digital PCR
12.2.2.1. Reagents & Consumables
12.2.2.2. Instruments
12.2.2.3. Software
12.3. Market Value Forecast, by Application, 2023–2031
12.3.1. Clinical Applications
12.3.2. Research Applications
12.3.3. Pathogen Testing
12.3.4. Oncology Testing
12.3.5. Blood Screening
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2023–2031
12.4.1. Hospitals & Diagnostic Centers
12.4.2. Research Laboratories & Academic Institutes
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Clinical Research Organizations
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2023–2031
13.2.1. Quantitative PCR
13.2.1.1. Reagents & Consumables
13.2.1.2. Instruments
13.2.1.3. Software
13.2.2. Digital PCR
13.2.2.1. Reagents & Consumables
13.2.2.2. Instruments
13.2.2.3. Software
13.3. Market Value Forecast, by Application, 2023–2031
13.3.1. Clinical Applications
13.3.2. Research Applications
13.3.3. Pathogen Testing
13.3.4. Oncology Testing
13.3.5. Blood Screening
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2023–2031
13.4.1. Hospitals & Diagnostic Centers
13.4.2. Research Laboratories & Academic Institutes
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Clinical Research Organizations
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2023–2031
14.2.1. Quantitative PCR
14.2.1.1. Reagents & Consumables
14.2.1.2. Instruments
14.2.1.3. Software
14.2.2. Digital PCR
14.2.2.1. Reagents & Consumables
14.2.2.2. Instruments
14.2.2.3. Software
14.3. Market Value Forecast, by Application, 2023–2031
14.3.1. Clinical Applications
14.3.2. Research Applications
14.3.3. Pathogen Testing
14.3.4. Oncology Testing
14.3.5. Blood Screening
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2023–2031
14.4.1. Hospitals & Diagnostic Centers
14.4.2. Research Laboratories & Academic Institutes
14.4.3. Pharmaceutical & Biotechnology Companies
14.4.4. Clinical Research Organizations
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2023–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Bio Rad Laboratories
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Thermo Fisher Scientific, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Qiagen
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. F. Hoffmann La Roche Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Abbott Laboratories
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Agilent Technologies
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. BD
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Danaher Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Merck KGaA
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Takara Bio, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
Table 01: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 02: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 03: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 04: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Region, 2023–2031
Table 05: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 06: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 07: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 08: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country, 2023–2031
Table 09: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 10: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 11: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 12: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 13: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 14: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 15: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 16: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 17: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 18: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 19: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 20: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 21: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 22: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 23: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 24: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
